Susceptibility of pneumococci to evernimicin: effect of CO2 and different methodologies
- 1 June 2001
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 7 (6) , 339-340
- https://doi.org/10.1046/j.1198-743x.2001.00252.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilutionClinical Microbiology & Infection, 2000
- Ziracin, a novel oligosaccharide antibiotic.The Journal of Antibiotics, 2000
- Antimicrobial activity of SCH27899 (Ziracin®), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/Etest method evaluations and quality control guidelinesDiagnostic Microbiology and Infectious Disease, 1999
- Susceptibility Testing of Linezolid by Two Standard MethodsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1999
- Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive SpectrumClinical Microbiology & Infection, 1995
- DIMINISHED EFFECT OF GENTAMICIN UNDER ANAEROBIC OR HYPERCAPNIC CONDITIONSThe Lancet, 1976